DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Elvucitabine is an investigational drug.
There have been 6 clinical trials for Elvucitabine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2006.
The most common disease conditions in clinical trials are HIV Infections, Immunologic Deficiency Syndromes, and Acquired Immunodeficiency Syndrome. The leading clinical trial sponsors are Achillion Pharmaceuticals, Bellos, Nicholaos C., M.D., and Thomas Jefferson University.
Recent Clinical Trials for Elvucitabine
|An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment||Bellos, Nicholaos C., M.D.||Phase 2|
|An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment||Center for the Prevention and Treatment of Infections||Phase 2|
|An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment||Central Texas Primary Care Research Network||Phase 2|